FDx Advisors
TEVA icon

FDx Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

FDx Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$587K Sell
14,831
-377
-2% -$13.5K 0.19% 84
2026
Q2 		$515K Sell
15,208
-428
-3% -$14.3K 0.16% 96
2026
Q1 		$471K Buy
+15,636
New +$503K 0.15% 99
2018
Q2 		– Sell
-36,198
Closed -$619K – 1084
2018
Q1 		$619K Sell
36,198
-2,667
-7% -$52.1K 0.02% 666
2017
Q4 		$736K Sell
38,865
-50,920
-57% -$766K 0.02% 649
2017
Q3 		$1.58M Buy
89,785
+13,658
+18% +$307K 0.04% 393
2017
Q2 		$2.53M Buy
76,127
+26,472
+53% +$819K 0.07% 235
2017
Q1 		$1.59M Buy
49,655
+5,987
+14% +$204K 0.05% 362
2016
Q4 		$1.58M Buy
43,668
+18,075
+71% +$722K 0.05% 355
2016
Q3 		$1.18M Sell
25,593
-8,247
-24% -$430K 0.05% 341
2016
Q2 		$1.7M Buy
33,840
+18
+0.1% +$958 0.08% 232
2016
Q1 		$1.81M Buy
33,822
+13,811
+69% +$810K 0.08% 214
2015
Q4 		$1.31M Buy
20,011
+10,064
+101% +$622K 0.06% 278
2015
Q3 		$562K Sell
9,947
-4,165
-30% -$270K 0.05% 414
2015
Q2 		$834K Sell
14,112
-1,088
-7% -$67.1K 0.04% 388
2015
Q1 		$946K Sell
15,200
-961
-6% -$55.9K 0.02% 624
2014
Q4 		$929K Buy
16,161
+6,225
+63% +$347K 0.06% 329
2014
Q3 		$534K Buy
+9,936
New +$526K 0.03% 560
2013
Q4 		– Sell
-42,101
Closed -$1.59M – 668
2013
Q3 		$1.59M Sell
42,101
-1,461
-3% -$57K 0.19% 117
2013
Q2 		$1.71M Buy
+43,562
New +$1.7M 0.23% 105

Other funds holding TEVA

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $20.7B AUM 58.31% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

FDx Advisors's TEVA Position: Q3 2026 in Review

FDx Advisors reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 2.5% in Q3 2026, selling an estimated $13.5K and leaving 14,831 shares worth $587K. The position accounts for 0.19% of the portfolio, ranked #84.

FDx Advisors first reported a position in TEVA in Q2 2013 and has held it in 20 quarters since. The position peaked at $2.53M in Q2 2017. 477 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • FDx Advisors held 14,831 shares of Teva Pharmaceutical Industries Limited worth $587K as of Q3 2026.
  • FDx Advisors sold 377 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $13.5K.
  • Teva Pharmaceutical Industries Limited made up 0.19% of FDx Advisors's portfolio in Q3 2026, its #84 holding.
  • FDx Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 20 quarters since.
  • FDx Advisors's Teva Pharmaceutical Industries Limited position peaked at $2.53M in Q2 2017.
  • 477 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on FDx Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.